One of the hallmarks of Alzheimer's disease is extracellular accumulation of senile plaques composed primarily of aggregated -amyloid (A) peptide. Treatment of cultured neurons with A peptide induces neuronal death in which apoptosis is suggested to be one of the mechanisms. We have demonstrated previously that A peptide induces activation of double-stranded RNA-dependent serine/threonine protein kinase (PKR) and phosphorylation of eukaryotic initiation factor 2␣ (eIF2␣) in neurons in vitro. Degenerating neurons in brain tissues from Alzheimer's disease patients also displayed high immunoreactivity for phosphorylated PKR and eIF2␣. Our previous data have also indicated that PKR plays a significant role in mediating A peptideinduced neuronal death, because neurons from PKR knockout mice and neuroblastoma SH-SY5Y cells stably transfected with dominant negative mutant of PKR are less susceptible to A peptide toxicity. Therefore, it is important to understand how PKR is activated by A peptide. We report here that inhibition of caspase-3 activity reduces phosphorylation of PKR and to a certain extent, cleavage of PKR and eIF2␣ in neurons exposed to A peptide. Calcium release from the endoplasmic reticulum and activation of caspase-8 are the upstream signals modulating the caspase-3-mediated activation of PKR by A peptide. Although in other systems HSP90 serves as a repressor for PKR, it is unlikely the candidate for caspase-3 to affect PKR activation in neurons after A peptide exposure. Elucidation of the upstream pathways for PKR activation can help us to understand how this kinase participates in A peptide neurotoxicity and to develop effective neuroprotective strategy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.